Back to GABELLI FUNDS LLC GABELLI FUNDS LLC

DXCMDXCM

Showing 8 of 30 quarters

Position history for GABELLI FUNDS LLCGABELLI FUNDS LLC's holdings in DEXCOM INC

Yes. Gabelli Funds holds 69,600 shares of DXCM (Dexcom), worth $4.7M, as of its Q2 2026 13F filing. It increased the position by 8,300 shares (+13.5%) from Q1 2026. Gabelli Funds has held DXCM in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$4.7M

Current Shares

69,600

Total Value Change

+$1.3M

Total Shares Change

+19,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
69,600
+13.5%
$4.7M0.0%$67.35
30
2026-Q1
Increased
61,300
+22.1%
$3.8M0.0%$62.80
32
2025-Q4
Increased
50,200
+0.4%
$3.3M0.0%$66.37
26
2025-Q3
Decreased
50,000
-0.6%
$3.4M0.0%$67.29
0
2025-Q2
Increased
50,300
+0.6%
$4.4M0.0%$87.29
27
2025-Q1
Unchanged
50,000
0.0%
$3.4M0.0%$68.29
0
2024-Q4
Unchanged
50,000
0.0%
$3.9M0.0%$77.77
0
2024-Q3
Unchanged
50,000
0.0%
$3.4M0.0%$67.04
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used